AtriCure, Inc.

NASDAQ:ATRC

Medical - Instruments & Supplies

Healthcare
$55.45 +3.52%

+$0.96 today

Market cap
$2.82B
Beta
1.26
P/E (TTM)
-295.5
EPS (TTM)
-$0.10
52W Low $25.36High $43.18

Volume 0.60M

Average 0.77M

ATRC Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

AtriCure, Inc.NASDAQ: ATRC

Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026

Cash & equivalents rises 42.4% from a year ago

Cash & equivalents stood at $167.79M at the end of Q2 FY2026, up 42.4% from a year earlier and up 14.8% from the prior quarter. Over 3 fiscal years it compounded at +42.3% a year.

Context

  • Cash & equivalents amounted to 24.8% of total assets at the end of Q2 FY2026, up 5.4 pp from a year earlier.
  • Cash & equivalents increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +42.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$167.79M+14.8% QoQ
Last fiscal yearDec 2025
$167.43M+36.4% YoY
Year agoJun 2025
$117.8M+42.4% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+42.4%——
1 year+36.4%——
3-year CAGR+42.3%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
167.43M USD
Year-over-year change
+36.4%
4-year CAGR
+39.9%

Cash & Equivalents vs competitors

How ATRC compares with its peers on the latest reported figures

  • ATRC's Jun 2026 cash & equivalents of $167.79M is the lowest of the 5 companies compared; the peer median is $1.13B.
  • Its year-over-year change of +42.4% is the highest of 5, against a peer median of -5.1%.
  • Cash & equivalents amounts to 24.8% of total assets for ATRC, versus a peer median of 11.3%.
ATRC Competitors Peer median
Cash & Equivalents for ATRC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
EWEdwards Lifesciences CorporationJun 2026$2.91B -11.2%+56.3%21.0%
MDTMedtronic plcJul 2026$1.69B +32.8%+8.1%1.8%
LIVNLivaNova PLCSep 2026$563.5M -12.8%+43.7%20.8%
BSXBoston Scientific CorporationJun 2026$539M +0.9%+30.1%1.2%
ATRCAtriCure, Inc.Jun 2026$167.79M +42.4%+42.3%24.8%
Peer median (excluding ATRC) $1.13B-5.1%+36.9%11.3%

Competitors are the stored peer set for ATRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents43.65M58.1M84.31M122.72M167.43M
Short-term Investments75.44M63.01M52.98M00
Net Receivables33.02M42.69M52.5M60.34M66.65M
Inventory38.96M45.93M67.9M75.34M78.49M
Other Current Assets008.56M9.43M9.94M
Total Current Assets196.08M215.21M266.25M267.83M322.52M
Property, Plant & Equipment (Net)36.17M42.62M46.76M47.39M45.99M
Goodwill234.78M234.78M234.78M234.78M234.78M
Intangible Assets42.99M39.34M63.99M56.47M48.03M
Long-term Investments104.34M51.51M000
Tax Assets00000
Other Non-current Assets955K1.99M2.16M2.87M2.86M
Total Non-current Assets419.24M370.23M347.69M341.5M331.66M
Total Assets615.31M585.45M613.93M609.33M654.18M
Account Payables18.6M19.9M27.35M25.03M78.4M
Short-term Debt03.33M2.53M2.81M3.12M
Tax Payables1.45M0000
Deferred Revenue00000
Other Current Liabilities33.41M2.8M2.75M42.63M0
Total Current Liabilities56.45M58.39M74.57M73.42M81.52M
Long-term Debt59.74M56.83M60.59M61.87M73.38M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.22M1.23M1.23M1.21M(4.17M)
Total Non-current Liabilities75.11M70.3M73.2M74.94M80.72M
Total Liabilities131.56M128.69M147.76M148.36M162.24M
Common Stock46K47K48K49K50K
Retained Earnings(280.15M)(326.62M)(357.06M)(401.76M)(413.2M)
Accumulated OCI(948K)(4.1M)(993K)(1.04M)566K
Other Stockholders Equity00000
Minority Interest00000
Total Equity483.76M456.75M466.17M460.97M491.94M
Total Debt75.65M74.55M74.49M76.53M88.02M
Net Debt31.99M16.45M(9.82M)(46.19M)(79.41M)

AtriCure, Inc.

NASDAQ:ATRC

Intrinsic Alpha fair value

Locked

Current Price

$55.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.